NEURL1 and neuroblastoma: A third genomic rearrangement (ALK-NEURL1) was detected in the plasma of a stage IV neuroblastoma patient (NB-pt03) and further confirmed by digital PCR, yielding similar VAFs (0.109 versus 0.069, respectively).